United Kingdom · Question · Written question
UIN 105615
Skin Diseases: Steroid Drugs
Introduced
17 January 2022
Last action
15 February 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 February 2022
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent topical steroid withdrawal reactions while tackling the severe reactions that can result from long term use of steroid-based dermatological treatments.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 January 2022
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent topical steroid withdrawal reactions while tackling the severe reactions that can result from long term use of steroid-based dermatological treatments.
Source: Commons
15 February 2022
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) reviewed topical steroid withdrawal and in September 2021 issued advice to inform prescribers and patients of the risks of long term treatment, which is available at the following link:https:/...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-01-17/105615
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1403381
- uk · wq-1403381 · source updated 15 February 2022